Abstract. The main objective of the present study was to establish significant and validated QSAR models for imidazoles and sulfonamides to explore the relationship between their physicochemical properties and antidiabetic activity. Two dimensional QSAR models had been developed by multiple linear regression and partial least square analysis methods, and then validated for internal and external predictions. The established 2D QSAR models were statistically significant and highly predictive. The validation methods provided significant statistical parameters with q 2 > 0.5 and pred_r 2 > 0.6, which proved the predictive power of the models. The developed 2D QSAR models revealed the significance of SlogP and T_N_O_5, and Mol.Wt and SsBrE-index properties of imidazoles and sulfonamides on their antidiabetic activity, respectively. These results should prove to be an essential guide for the further design and development of new imidazoles and sulfonamides having better antidiabetic activity.
Introduction
The discovery and development of a new chemical entity with demonstrated utility in ameliorating or curing disease is a long and arduous process. Industry statistics suggests that up to several thousand compounds are synthesized and tested; up to 100 compounds are assessed for safety; and up to 10 compounds are tested clinically in humans for every drug that is approved for medical use. Trial and error screening used to consider as the normal procedure, is becoming very costly and at the same time less efficient. Therefore, only molecules with good chance of activity should be prepared and tested. In this context, proper designing is required before synthesis of the drugs.
Diabetes is a complex and costly disease that can affect nearly every organ in the body and result in devastating consequences [1] . Diabetes is the major causes of renal failure, blindness [2] , stroke, cardiovascular disease, premature and perinatal mortality [3] . Insulin is the choice of treatment for type 1 diabetes. Type 2 diabetes can be managed with a combination of different oral and injectable antidiabetic agents [4] .
In rational drug design, numerous 2D QSAR studies [5] [6] [7] [8] [9] [10] , 3D QSAR studies [11, 12] and binding studies [13] have been reported for different group of chemical derivatives and their antidiabetic activity. With the aim of developing good antidiabetic drugs, we have selected some imidazole and sulfonamide antidiabetic compounds [14] [15] [16] [17] to understand structural insight, which is responsible for selectivity of these derivatives towards diabetes by using QSAR analysis. The series of compounds had shown well defined activity. There was high structural diversity and a sufficient range of the biological activity in the series of compounds selected for the present study. The developed QSAR models were statistically significant and could efficiently guide to 2.3. Energy minimization "The geometry of the 3D structures was optimized to local minima by Merck Molecular Force Field (MMFF) by considering distance-dependent dielectric constant of 1.0, convergence criterion or root-mean-square (RMS) gradient at 0.001 kcal/mol Å and the iteration limit to 10,000. Most stable structure for each compound was generated and saved as .mol2 files for computing various physico-chemical and alignment independent descriptors" [18] .
Calculation of descriptor (Independent variable)
The energy-minimized structures were used for the calculation of the various 2D descriptors like physicochemical (200 in numbers) and other alignment independent descriptors (700 in numbers). The preprocessing of the independent variables (i.e., 2D descriptors) was done by removing invariables and variable exclusion was done for constant variable or near constant variable at paired correlation. Finally all together 300 descriptors were selected to develop models.
Training and test set selection
Division of compounds into training and test data set was done by using sphere exclusion (SE) and random selection methods. The dissimilarity value 1 and 1.5 was used in sphere exclusion method, where the dissimilarity value is the sphere exclusion radius. In random selection method selection of training set compounds with four trials 70, 75, 80 and 85% were tried [19] . The reported IC50 or Ki values of the selected series of compounds for the present QSAR study as their negative logarithmic concentrations [-logIC50 or pIC50 or pKi], where IC50 is the micro molar concentration of the compounds producing 50% inhibition in the glucagon receptor activity [14] and Ki is carbonic anhydrase II inhibitor activity [15] [16] [17] .
Feature selection and model development
In the present study, stepwise (SW) forward-backward variable selection [20] , genetic algorithms (GA) [21] and simulated annealing (SA) [22] based feature selection procedures were used to build QSAR models. The crosscorrelation limit 0.5, the number of variables 5, and the term selection criteria q² was used to build QSAR models. The variance cutoff of 0 and auto-scaling with number of random iterations 100 was used to normalize the independent variables.
The stepping criteria for inclusion of predictor variable F = 4 and exclusion of predictor variable F = 3.99 was used in SW forward-backward variable selection algorithm. Population 10, number of generations 1000 and speed of 9999 was used in GA method. The maximum and minimum temperature used in SA method was 100 K and 0.01 K, and it was decreased by 5 units with 100 iterations at that particular temperature [18] .
Multiple linear regression and partial least square analysis were used to find the relation between the dependent and independent variables. The relationship between dependent variable and various independent variables were established by using QSAR module of VLife MDS software.
Model quality and validation
The developed QSAR models are evaluated using the following statistical measures: n (the number of compounds in regression); k (number of variables); DF (degree of freedom); r² (squared correlation coefficient); r²se (standard error of r²); F test (Fischer's value); q² (cross-validated squared correlation coefficient); q²_se (standard error of q²); pred_r² (r² for external test set); pred_r²se (standard error of pred_r²); Z score (Z score calculated by the randomization test); best_ran_q² (highest q 2 value in the randomization test); best_ran_r² (highest r² value in the randomization test). A QSAR model is considered to be predictive, if the following conditions are satisfied: r² > 0.7, q² > 0.5 and pred_r² > 0.6 [23] . The quality and validation parameters of QSAR models are compiled and discussed in detail somewhere by Ravichandran et al. [24] .
Results and discussion

Series I: Triaryl imidazoles
The glucagon antagonist activity and structure of 27 compounds ( Table 1 ) was taken from the study reported by Chang et al. after excluding 11 molecules which were not having a well-defined biological activity, and 3 molecules that are not congeners to the rest of the dataset [14] . Different feature selection and model development methods were used to develop 2D QSAR models. One of the best developed models was Eq. Eq. (1) could explain 91.7% and predict 83.0% of the variance of the antidiabetic data. There was no intercorrelation between the descriptors. The parameters involved in the selected model (SlogP, T_N_O_5) and the calculated antidiabetic activity by Eq. (1) are given in Table 2 . The correlation of experimental activity against predicted activities by Eq. (1) is graphically represented in Figure 1 . The closeness of the actual and predicted activity by Eq. (1) for training and test set compounds are shown in Figure 2 The developed MLR model reveals that the descriptor T_N_O_5 which is an alignment independent descriptor showed positive contribution. Such positive effect indicates that the antidiabetic activity is increased with increase in the count of number of nitrogen atom (single, double or triple bonded) separated from any oxygen atom (single, double or triple bonded) by 5 bond distance in a molecule. These findings were supported by the compounds 22, 23, 24, 25, 26 and 27 which have substitution of 2-OPh-Ph, 3-OPh-Ph, 4-OPh-Ph, 2-OnBu-Ph, 2,4-(O-nPr)2-Ph or 2,4-(O-nBu)2-Ph at C-4 position (R2) of imidazole. The other descriptor SlogP signifies log of the octanol/water partition coefficient (Including implicit hydrogen). The positive contribution SlogP suggests that the antidiabetic activity is increased with substitution of strong hydrophobic groups. These findings were supported by the compounds 18 to 27 which have substitution of strong hydrophobic groups specifically at C-4 position of imidazole (R2). Modification of the parameters T_N_O_5 and SlogP for the present series of compounds will lead to good effect on antidiabetic activity.
Series II: Aromatic sulfonamides
The carbonic anhydrase II inhibitory activity and structure of 47 compounds (Table 3) were used for the present study [15] [16] [17] . Different feature selection and model development methods were used to develop 2D QSAR models. One of the best developed models was Eq. (2) could explain 66.3% and predict 71.4% of the variance of the carbonic anhydrase II inhibitory activity data. There was no inter-correlation between the descriptors. The parameters involved in the selected model (Molecular weight and SsBrE-index) and the calculated antidiabetic activity by Eq. (2) are given in Table 4 .
The correlation of experimental activity against predicted activities by Eq. (2) is graphically represented in Figure 4 . The closeness of the actual and predicted activity by Eq. (2) for training and test set compounds are shown in Figure 5 and 6, respectively. The selected model was good in internal prediction (q 2 = 0.846) and external prediction (pred_r 2 = 0.714). The good results in our original model are not due to a chance correlation or structural dependency of the compounds was buttressed by the low randomized r 2 (0.201) and q 2 (0.082) values. The developed MLR model reveals that the descriptor molecular weight showed positive contribution. Such positive effect indicates that the antidiabetic activity is increased with substitution of bulky groups in the compounds. These findings were supported by the compounds 5, 6, 12, 13 and 14 which have high molecular weight. The other descriptor, SsBrE-index is an electrotopological indices descriptor influencing activity variation and is directly contributing to activity. This descriptor reveals the importance of presence of number of bromine atom connected with one single bond in the compounds. Carbonic anhydrase II inhibitory activity of sulfonamides is increased with substitution of more bromine. Modification of the parameters molecular weight and SsBrE-index in the present series of sulfonamide compounds will lead to good effect on antidiabetic activity.
Conclusion
In the present study, statistically significant and highly predictive 2D QSAR models were developed for some antidiabetic compounds. The QSAR models were validated by standard statistical measures, crossvalidated correlation coefficient, external test set and randomization test, and through observation on how it reproduces and explains the quantitative differences seen in the experimentally known activity data. The models are considered predictive model as the validation methods provided significant statistical parameters with q 2 = 0.880, 0.623 and pred_r 2 = 0.830, 0.714, respectively for model 1 and 2. The developed 2D QSAR models revealed the importance of SlogP, T_N_O_5, Mol.Wt and SsBrE-index properties of compounds in their antidiabetic activity. These results will be an essential guide for the further design and development of new lead compounds of more potent antidiabetic compounds.
These studies can be further extended to develop QSAR models using some other approaches HQSAR, PARM, 3D QSAR and docking analysis of direct drug designing and further validation of the results obtained in the present studies. The field is further open for designing, synthesis and biological evaluation of potent antidiabetic compounds, pharmacokinetic studies and clinical studies to establish those molecules as drug.
